The correlation between anti-Jo-1 levels and disease activity in different subgroups were shown in Supplementary Table 3 (with and without ILD and baseline), Supplementary Table 4 (with and without anti-Ro-52) and Supplementary Table 5 (treated and treatment naive), and no significant correlation was found. This evidence concerns the gene TRIM21 and interstitial lung disease.